| [1] | OZTURK A. Role of annexin A3 in breast cancer(Review)[J]. Mol Clin Oncol, 2022, 16(6):111. doi: 10.3892/mco.2022.2544 |
| [2] | TONG M, CHE N, ZHOU L, et al. Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib[J]. J Hepatol, 2018, 69(4):826-839. doi: 10.1016/j.jhep.2018.05.034 |
| [3] | 孙佳, 肖海娟, 闫克敏, 等. 下调Annexin A3基因对结肠癌HCT116/L-OHP细胞生物学特性影响[J]. 中华肿瘤防治杂志, 2019, 26(11):771-777. |
| [4] | WAN X H, GUO D R, ZHU Q, et al. MicroRNA-382 suppresses the progression of pancreatic cancer through the PI3K/Akt signaling pathway by inhibition of Anxa3[J]. Am J Physiol Gastrointest Liver Physiol, 2020, 319(3):G309-G322. doi: 10.1152/ajpgi.00322.2019 |
| [5] | 王胜涛, 李朝旭. 膜联蛋白A3与肿瘤关系的研究进展[J]. 世界最新医学信息文摘, 2018, 18(24):52-53,58. |
| [6] | 马聪聪, 陆红祥, 史清海. 膜联蛋白A3在相关疾病诊疗中的研究进展[J]. 新疆医学, 2022, 53(6):628-631,638. doi: 10.3969/j.issn.1001-5183.2022.6.xjyx202206004 |
| [7] | 柴嘉音, 薛可, 王雯. 膜联蛋白A3在心血管系统中的作用[J]. 中国动脉硬化杂志, 2022, 30(10):846-851. doi: 10.3969/j.issn.1007-3949.2022.10.004 |
| [8] | LIAO C C, LIN Y L, KUO C F. Effect of high-fat diet on hepatic proteomics of hamsters[J]. J Agric Food Chem, 2015, 63(6):1869-1881. doi: 10.1021/jf506118j |
| [9] | ZHOU T, LIU S, YANG L, et al. The expression of ANXA3 and its relationship with the occurrence and development of breast cancer[J]. J BUON, 2018, 23(3):713-719. |
| [10] | ZHOU T, LI Y, YANG L, et al. Silencing of ANXA3 expression by RNA interference inhibits the proliferation and invasion of breast cancer cells[J]. Oncol Rep, 2017, 37(1):388-398. doi: 10.3892/or.2016.5251 |
| [11] | KIM J Y, JUNG E J, PARK H J, et al. Tumor-suppressing effect of silencing of annexin A3 expression in breast cancer[J]. Clin Breast Cancer, 2018, 18(4):e713-e719. doi: 10.1016/j.clbc.2017.11.009 |
| [12] | PAN Q Z, PAN K, WENG D S, et al. Annexin A3 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma[J]. Mol Carcinog, 2015, 54(8):598-607. doi: 10.1002/mc.22126 |
| [13] | WANG L M, LI X Q, REN Y H, et al. Cancer-associated fibroblasts contribute to cisplatin resistance by modulating ANXA3 in lung cancer cells[J]. Cancer Sci, 2019, 110(5):1609-1620. doi: 10.1111/cas.13998 |
| [14] | 吴敏, 李丽, 陈鹏飞, 等. 萝卜硫素通过ANXA3/p38和JNK信号通路诱导人皮肤鳞状细胞癌细胞凋亡[J]. 中国中西医结合皮肤性病学杂志, 2022, 8(5):398-403. |
| [15] | DU K L, REN J H, FU Z X, et al. ANXA3 is upregulated by hypoxia-inducible factor 1-alpha and promotes colon cancer growth[J]. Transl Cancer Res, 2020, 9(12):7440-7449. doi: 10.21037/tcr-20-994 |
| [16] | GAO S H, WANG Z Z, LIU X Z, et al. The calcimedin annexin A3 displays tumor-promoting effect in esophageal squamous cell carcinoma by activating NF-κB signaling[J]. Mamm Genome, 2021, 32(5):381-388. doi: 10.1007/s00335-021-09883-3 |
| [17] | ZHOU T, LI Y, YANG L, et al. Annexin A3 as a prognostic biomarker for breast cancer: a retrospective study[J]. Biomed Res Int, 2017, 2017:2603685. |
| [18] | LIANG Y X, MIN D L, FAN H L, et al. Discovery of a first-in-class ANXA3 degrader for the treatment of triple-negative breast cancer[J]. Acta Pharm Sin B, 2023, 13(4):1686-1698. doi: 10.1016/j.apsb.2022.11.023 |
| [19] | WANG K, LI J S. Overexpression of ANXA3 is an independent prognostic indicator in gastric cancer and its depletion suppresses cell proliferation and tumor growth[J]. Oncotarget, 2016, 7(52):86972-86984. doi: 10.18632/oncotarget.13493 |
| [20] | XU R S, YIN J, ZHANG Y, et al. Annexin A3 depletion overcomes resistance to oxaliplatin in colorectal cancer via the MAPK signaling pathway[J]. J Cell Biochem, 2019, 120(9):14585-14593. doi: 10.1002/jcb.28720 |
| [21] | XU B, ZHANG X P, GAO Y, et al. Microglial Annexin A3 promoted the development of melanoma via activation of hypoxia-inducible factor-1α/vascular endothelial growth factor signaling pathway[J]. J Clin Lab Anal, 2021, 35(2):e23622. doi: 10.1002/jcla.23622 |
| [22] | GUO C M, LI N N, DONG C Y, et al. 33-kDa ANXA3 isoform contributes to hepatocarcinogenesis via modulating ERK, PI3K/Akt-HIF and intrinsic apoptosis pathways[J]. J Adv Res, 2021, 30:85-102. doi: 10.1016/j.jare.2020.11.003 |
| [23] | 罗文, 张科, 刘海军. 血清膜联蛋白A3联合缺氧诱导因子-1α在结直肠癌铂类耐药预测中的应用研究[J]. 实用临床医药杂志, 2023, 27(5):67-71. doi: 10.7619/jcmp.20223174 |
| [24] | SUN Y L, WU C S, MA J X, et al. Toll-like receptor 4 promotes angiogenesis in pancreatic cancer via PI3K/AKT signaling[J]. Exp Cell Res, 2016, 347(2):274-282. doi: 10.1016/j.yexcr.2016.07.009 |
| [25] | LI D Q, LIN M, ABDELRAHMAN Z. High expression of the ANXA3 gene promotes immune infiltration and improves tumor prognosis in ovarian serous carcinoma using bioinformatics analyses[J]. Ann Transl Med, 2022, 10(19):1055. doi: 10.21037/atm-22-3726 |
| [26] | PAN Q Z, PAN K, WANG Q J, et al. Annexin A3 as a potential target for immunotherapy of liver cancer stem-like cells[J]. Stem Cells, 2015, 33(2):354-366. doi: 10.1002/stem.1850 |
| [27] | ZHU Q, PAN Q Z, ZHONG A L, et al. Annexin A3 upregulates the infiltrated neutrophil-lymphocyte ratio to remodel the immune microenvironment in hepatocellular carcinoma[J]. Int Immunopharmacol, 2020, 89(Pt A): 107139. |
| [28] | ZHANG Z L, DENG M L, HUANG J J, et al. Microglial annexin A3 downregulation alleviates bone cancer-induced pain through inhibiting the Hif-1α/vascular endothelial growth factor signaling pathway[J]. Pain, 2020, 161(12):2750-2762. doi: 10.1097/j.pain.0000000000001962 |
| [29] | MENG H, ZHANG Y, AN S T, et al. Annexin A3 gene silencing promotes myocardial cell repair through activation of the PI3K/Akt signaling pathway in rats with acute myocardial infarction[J]. J Cell Physiol, 2019, 234(7):10535-10546. doi: 10.1002/jcp.27717 |
| [30] | HUANG G D, ZHONG X F, DENG Z Y, et al. Proteomic analysis of ginsenoside Re attenuates hydrogen peroxide-induced oxidative stress in human umbilical vein endothelial cells[J]. Food Funct, 2016, 7(5):2451-2461. doi: 10.1039/C6FO00123H |
| [31] | HUANG K T, CRIST A M, PATEL N R, et al. Annexin A3 is necessary for parallel artery-vein alignment in the mouse retina[J]. Dev Dyn, 2020, 249(5):666-678. doi: 10.1002/dvdy.154 |
| [32] | 梁冰, 方洁. 靶向沉默ANXA3对大鼠吗啡镇痛耐受及炎症反应的影响[J]. 解放军医学杂志, 2020, 45(1):68-72. |
| [33] | TOUFIQ M, ROELANDS J, ALFAKI M, et al. Annexin A3 in sepsis: novel perspectives from an exploration of public transcriptome data[J]. Immunology, 2020, 161(4):291-302. doi: 10.1111/imm.13239 |
| [34] | LI M L, LIU D, JING F C, et al. The role of Annexin A3 in coronary arterial lesions in children with Kawasaki disease[J]. Front Pediatr, 2023, 11:1111788. doi: 10.3389/fped.2023.1111788 |
| [35] | RÖSCH K, KWIATKOWSKI M, HOFMANN S, et al. Quantitative lipid droplet proteome analysis identifies annexin A3 as a cofactor for HCV particle production[J]. Cell Rep, 2016, 16(12):3219-3231. doi: 10.1016/j.celrep.2016.08.052 |
| [36] | LIN S, LI M Z, ZHOU Y K, et al. Annexin A3 accelerates osteoclast differentiation by promoting the level of RANK and TRAF6[J]. Bone, 2023, 172:116758. doi: 10.1016/j.bone.2023.116758 |
| [37] | JACINTHO B C, MAZETTO FONSECA B M, HOUNKPE B W, et al. Evaluation of a gene signature related to thrombotic manifestations in antiphospholipid syndrome[J]. Front Med, 2023, 10:1139906. doi: 10.3389/fmed.2023.1139906 |
| [38] | MIN X L, HE M, SHI Y, et al. MiR-18b attenuates cerebral ischemia/reperfusion injury through regulation of ANXA3 and PI3K/Akt signaling pathway[J]. Brain Res Bull, 2020, 161:55-64. doi: 10.1016/j.brainresbull.2020.04.021 |